News BERG works with advocacy group on rare disease awareness Partnership with debra of America looks to raise awareness of lead candidate.
Views & Analysis Digital Health Round-up - Is AI the future of cancer drug de... Does artificial intelligence hold the key to cancer drug R&D?
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.